News

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
Large, lengthy studies will be needed for the agency to approve boosters for healthy adults and children, regulators said.
Nuvaxovid had been available under emergency use authorization but the full approval may allow it to better compete with ...